Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

F. Hoffmann-La Roche Ltd.

Facebook Twitter LinkedIn Email Comments
F. Hoffmann-La Roche Ltd. of Basel, Switzerland, has purchased 454 Life Sciences of Branford, Conn., a majority-owned subsidiary of CuraGen Corp., also of Branford. Under terms of the agreement, Roche will pay holders of the acquired company’s shares a total of $140 million in cash. The shareholders may receive up to $14.9 million in additional cash from holders of currently outstanding stock options and warrants. The employees of 454 Life Sciences, which develops and commercializes instrumentation for high-throughput DNA sequencing, will remain at their current location and become part of the Roche Diagnostics Div.

BioPhotonics
May 2007
BiophotonicsDNAF. Hoffmann-La Roche Ltd.News & Features

Comments
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.